Boult Wade Tennant
Bulletins » EU-based and filing patent applications in an EU language other than English, French, or German? Receive a €500 translation fee reimbursement under the Unitary Patent System

One of the major sticking points in the creation of the Unitary Patent system (which now covers 18 EU countries) was the debate as to which languages would be used, and in what capacity.

Plainly, for a Unitary Patent to be cost effective, requiring translations into the national languages of each contracting state is not feasible. However, there is clearly a legitimate question about whether this unfairly prejudices proprietors or alleged infringers who work in contracting states with different official languages to those used by the UPC. This argument was raised in a case before the CJEU by Spain, who were opposed to the UPC’s proposed reliance on English, French and German, and ultimately decided not to join the Unitary Patent System.

One feature of the Unitary Patent (UP) system is a valuable benefit for smaller applicants: a €500 flat‑rate reimbursement to help cover translation costs during the patent application process.

What is the compensation scheme?
To ease translation-related expenses for eligible applicants, the European Patent Office (EPO) offers a €500 lump-sum reimbursement as part of the Unitary Patent compensation scheme.

To be eligible, the applicant must be either an SME, natural person, non-profit organisation, university, or public research organisation. The European patent application or Euro-PCT application leading to the UP must have been filed in an official EU language other than English, French, or German.

The applicant must also have their residence or principal place of business in an EU member state.

Currently, a translation of the granted specification into English if the language of the proceedings before the EPO was French or German, or into any other EU language if the language of proceedings was English, is required for Unitary Patent validation. For EU-based applicants meeting the criteria above and seeking UP protection, it may therefore be worth considering filing a European patent application in an admissible non-EPO language (i.e., an EU language other than English, French, or German). However, it should be borne in mind that after the transitional period of six years (which may be extended up to a maximum of 12 years), such translations will no longer be required when opting for a Unitary Patent.

How and when to request the reimbursement
Applicants must submit their reimbursement request together with the request for unitary effect. Evidence for eligibility is not required, however the EPO may subsequently request evidence of eligibility.

The compensation is awarded only after unitary effect has been entered in the Register for Unitary Patent Protection.

An informed choice in relation to translations can therefore be used to reduce the cost of obtaining Unitary Patent protection. To find out more about obtaining Unitary Patent protection, contact your usual Boult representative, or email boult@boult.com.

Relevant sectors
Aerospace
  • Commercial aviation
  • Defence and security
  • Space and satellites
  • Unmanned aerial vehicles
Artificial Intelligence and Machine Learning
Automotive
  • Autonomous vehicles
  • Electric vehicles
  • Engines
Biotechnology
  • Antibody engineering
  • Antibody manufacture and formulation
  • Bioinformatics
  • Biosimilars
  • Drug delivery
  • Gene editing (e.g. CRISPR)
  • Genomic and molecular tools and methods
  • GM crops
  • Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
  • Next generation sequencing
  • Nucleic acid synthesis
  • Personalised medicine/disease biomarkers
  • Recombinant protein production and purification
  • Stem cell therapies
  • Supplementary protection certificates (SPCs)
  • Synthetic biology
  • Therapeutic antibodies
  • Vaccinology (e.g. viral vectors; mRNA vaccines)
  • Women’s health products
Chemicals
  • Agrochemicals
  • Catalysts
  • Dispersions and colloids
  • Lubricants
  • Polymers and plastics
Communications and Networks
  • Cloud computing
  • Internet of things (IOT)
  • Oceanography, marine
  • Wired and wireless networks
Computing and Software
  • Artificial intelligence and machine learning
  • Bioinformatics
  • Blockchain and distributed ledgers
  • Communications and networks
  • Computer games
  • Data and software security, cryptography and digital rights management (DRM)
  • Data management and storage, databases and data compression
  • Digital assistants, virtual assistants and software agents
  • Fintech and adtech
  • Machine vision
  • Metaverse, virtual reality (VR) and augmented reality (AR)
  • Motor capture
  • Multimedia, audio/video processing and animation
  • Natural language processing
  • Quantum computing
  • Robotic process automation
  • Search engines
  • Signal processing
  • Software applications and systems, mobile applications, user interfaces
Consumer Goods and Retail
  • Anti-counterfeit devices
  • Beauty
  • Fashion
  • Health, fitness and sport
  • Household goods
  • Luxury goods
  • Moda
  • Retail
Electronics and Electrical Devices
  • Computer and IT architecture and system design
  • Medical devices
  • Optics
  • Restaurants and bars
  • Robotics
  • Scientific instruments
  • Semiconductor devices
  • Testing systems, control systems, signal processing
  • Travel and leisure
  • Wearable tech and human interfaces
Energy and Green Technologies
  • Biofuels
  • Clean air
  • Fuel cells and battery technology
  • Renewables and recycling
  • Solar power
  • Water, oil and gas, nuclear, fusion, fission
  • Wind turbines
Food and Beverage
  • Beverages
  • Nutrition
  • Retail
Industrial Manufacturing and Processing
  • Packaging
  • Polymers and plastics
  • Printing tech
  • Additive manufacturing
  • Coatings
  • Construction
Materials
  • Advanced materials
  • Composite materials
  • Metallurgy and alloys
  • Nanotechnology
Medical Devices and Diagnostics
  • Artificial intelligence
  • Devices
  • Diagnostic instruments
  • Digital health
  • Drug delivery
  • Immuno-oncology
  • In vitro diagnostics
  • Medtech
Pharmaceuticals
  • Diagnostics
  • Drug delivery
  • Generic market entry
  • Medicinal chemistry
  • Methods of production and synthesis
  • Personalised medicine/disease biomarkers
  • Pharmaceutical formulations
  • Pharmaceuticalsceutical formulations
  • Polymorphs
  • Small molecule pharmaceuticals
  • Supplementary protection certificates (SPCs)
Trade Marks
  • Consumer goods
  • Cosmetics and perfumery
  • Financial services
  • Mechanical engineering
  • Mechanical products
  • Services
  • Telecommunications
Relevant sectors